TEVA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Teva Pharmaceutical Industries Ltd

Watchlist Manager

Watchlist

Price: 34.56 USD 2.92% Market Closed

Market Cap: $39.2B

	Teva Pharmaceutical Industries Ltd NYSE:TEVA	IL
	Medpace Holdings Inc NASDAQ:MEDP	US
	CTS Corp F:XT1	US
N	Norditek Group AB F:O5D	SE
F	FormFactor Inc F:FMF	US
C	Cheniere Energy Inc F:CHQ1	US
B	Bank of Nova Scotia F:BKN	CA
L	Linde PLC DUS:LIN	UK
J	Japan Post Bank Co Ltd SWB:5JP	JP
G	Gilead Sciences Inc XBER:GIS	US
H	Home Depot Inc SGO:HD	US
H	Host Hotels & Resorts Inc F:HMT	US
	Trafalgar Property Group PLC LSE:TRAF	UK
B	Basf Se SWB:BAS	DE
	Bankinter SA F:BAKA	ES
	Aedifica NV F:AOO	BE
	Catena AB LSE:0GVS	SE

Profitability Summary

Teva Pharmaceutical Industries Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

53%

Strong 3Y Average Gross Margin

51%

Gross Margin is Increasing

49% > 53%

Healthy Operating Margin

24%

Sustainable 3Y Average Operating Margin

23%

Operating Margin is Increasing

20% > 24%

Low Net Margin

Negative 3Y Average Net Margin

-3%

Net Margin is Increasing

-11% > 9%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

6% > 7%

Positive ROE

22%

Negative 3Y Average ROE

Positive 3Y Average ROIC

17%

ROIC is Increasing

5% > 14%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.